UCITS Alternatives to PHARMABEES (Nippon India Nifty Pharma ETF)
PHARMABEES is a popular ETF listed on the IN market. It tracks the Nifty Pharma. Due to EU regulations (MiFID II/PRIIPs), European investors cannot directly purchase non-UCITS ETFs. We found 7 UCITS-compliant alternatives that provide similar market exposure.
UCITS Alternatives
7 found| ETF Name | ISIN | TER | AUM | Dist. | Replication |
|---|---|---|---|---|---|
| SimilariShares MSCI India UCITS ETF USD (Acc) | IE00BZCQB185 |
0.65% | €4.5B | Acc | Physical |
| SimilariShares MSCI India UCITS ETF USD (Acc) | IE00BYTH5R14 |
0.65% | €4.5B | Acc | Physical |
| ProxyiShares S&P 500 Health Care Sector UCITS ETF USD (Acc) | IE00B43HR379 |
0.15% | €3.5B | Acc | Physical |
| ProxyXtrackers MSCI World Health Care UCITS ETF 1C | IE00BM67HK77 |
0.25% | €2.8B | Acc | Physical |
| ProxyiShares MSCI World Health Care Sector UCITS ETF | IE00BMW42843 |
0.25% | €2.5B | Acc | Physical |
| ProxyXtrackers MSCI World Health Care UCITS ETF 1C | LU0533033667 |
0.25% | €1.8B | Acc | Physical |
| ProxyiShares Nasdaq US Biotechnology UCITS ETF | IE00BYVJRP78 |
0.35% | €1.0B | Acc | Physical |
About PHARMABEES
Where to Buy UCITS ETFs
FAQ
What does PHARMABEES track?
PHARMABEES (Nippon India Nifty Pharma ETF) is an ETF listed on IN that tracks the Nifty Pharma. It is one of the popular ETFs in its category.
Why can't I buy PHARMABEES in Europe?
Under EU MiFID II and PRIIPs regulations, brokers in the European Economic Area cannot sell ETFs that don't provide a Key Information Document (KID) in the local language. Most non-EU ETFs, including PHARMABEES, don't comply with these requirements.
What is the best UCITS alternative to PHARMABEES?
The closest UCITS alternative is iShares MSCI India UCITS ETF USD (Acc) (IE00BZCQB185). We identified 7 UCITS ETFs that offer similar exposure. Compare them in the table above to find the best fit.